Connect with us
European Gaming Congress 2024

Fintech PR

ADGM, the Region’s Leading Climate Finance Hub, Announces its Role as Principal Partner at COP28

Published

on

adgm,-the-region’s-leading-climate-finance-hub,-announces-its-role-as-principal-partner-at-cop28
  • ADGM will host the ‘Climate Finance Action Pavilion’ and showcase its thriving climate finance ecosystem.
  • ADGM has successfully introduced the region’s first comprehensive sustainable finance regulatory framework and environmental instruments to its capital markets framework, bringing the world’s first regulated voluntary carbon exchange, AirCarbon Exchange (ACX) under its jurisdiction.
  • ADGM chairs the UAE Sustainable Finance Working Group (SFWG) composed of UAE regulatory authorities, Federal Ministries and exchanges.

ABU DHABI, United Arab Emirates, Nov. 21, 2023 /PRNewswire/ — Abu Dhabi Global Market (ADGM), the international financial centre of UAE’s capital, announced today its appointment as ‘Principal Climate Finance Partner’ at COP28, set to run in the UAE from 30th November to 12th December 2023. This partnership highlights ADGM’s strategic emergence as the leading climate finance hub in the region, which has been supporting capital formation and deployment as well as the creation and issuance of innovative financial products and regulations to achieve progress towards bridging an estimated USD 11 trillion of capital needed for net-zero by 2050.

As the Principal Climate Finance Partner, ADGM will be staging a series of strategic negotiations and interactive discussions across the blue and the green zones showcasing its thriving climate finance ecosystem during COP28.

Presented on the thematic day of “Finance, Trade & Gender Equality” at COP28, ADGM will also host on 4th December 2023, its sixth edition of the Abu Dhabi Sustainable Finance Forum (ADSFF) in partnership with Masdar a major initiative within, as part of the Abu Dhabi Sustainability Week platform. This year’s ADSFF holds added importance as it marks the UAE’s year of sustainability and serves as a global platform to convene influential international leaders’ commitment to addressing the USD 11 Trillion climate financing gap faced globally and representing the UAE and Abu Dhabi as a ‘Capital of Green Capital’.

The upcoming forum is set to feature high-profile C-level executives hailing from renowned global financial institutions, including JP Morgan Chase, Morgan Stanley, BNP Paribas, General Atlantic, Tikehau Capital and Euroclear, Southbridge, One Planet Sovereign Wealth Fund (OPSWF). The agenda is rich with key progress milestones, notably the unveiling of the evolving investment strategies employed by Sovereign Wealth Funds in partnership with OPSWF. Additionally, an exclusive interview will examine Abu Dhabi’s ascent as a rising capital of climate finance, accompanied by a significant announcement from the Lord Mayor of the City of London.

The event promises special insights into the ever-evolving regulatory landscape surrounding climate finance, with a dedicated focus on enhancing carbon markets and fostering innovation in financing solutions. Attendees can also anticipate a compelling interview with the President of JP Morgan Chase, shedding light on one of the world’s largest banks and its strategic approach to financing the transition. This forum is poised to deliver valuable perspectives and updates at the forefront of global finance.

Commenting on the significance of COP28 and its participation, H.E Ahmed Jassim Al Zaabi Chairman of ADGM said, “We are honoured to take on the pivotal role of Principal Climate Finance Partner at COP28, a testament to our enduring commitment to sustainable finance and environmental stewardship. The upcoming gathering of world leaders in the UAE is poised to be a decisive moment, promising to be an impactful and inclusive ‘Conference of the Parties,’ emphasising inclusivity and solutions-driven dialogue. We look forward to actively contributing to COP28’s objectives and leaving a lasting legacy in climate finance in the UAE and beyond.”

Advertisement
Stake.com

ADGM’s strategic presence at COP28 represents another milestone in its ongoing contribution to sustainability-related initiatives. The international financial centre successfully introduced the region’s first comprehensive regulatory framework for Sustainable Finance, encompassing the region’s most extensive ESG disclosure requirements for relevant entities within ADGM and regulations for funds, discretionary managed portfolios, bonds and sukuks designed to accelerate the transition of the UAE to net zero greenhouse gas emissions. Another regulatory amendment last year introduced an environmental instrument as a class of financial instrument, allowing carbon offsets to come under its regulatory framework and bringing the world’s first regulated voluntary carbon exchange, AirCarbon Exchange (ACX), to Abu Dhabi.

In its efforts to build collaboration and strengthen the sustainability agenda across Abu Dhabi and the UAE, ADGM in 2019 established the UAE Sustainable Finance Working Group (SFWG) composed of UAE regulatory authorities, Federal Ministries and exchanges and continues to take the initiative for the Abu Dhabi Sustainable Finance Declaration, which has over 100 signatories.

These endeavours position ADGM’s dedication to advancing sustainable practices, building a Green Financial Centre of the future with a strong focus on environmental, social, and governance considerations.

Logo – https://mma.prnewswire.com/media/2211082/4274742/ADGM_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/adgm-the-regions-leading-climate-finance-hub-announces-its-role-as-principal-partner-at-cop28-301994757.html

Advertisement
Stake.com
Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Fintech PR

Invitation to presentation of EQT AB’s Q1 Announcement 2024

Published

on

invitation-to-presentation-of-eqt-ab’s-q1-announcement-2024

STOCKHOLM, April 5, 2024 /PRNewswire/ — EQT AB’s Q1 Announcement 2024 will be published on Thursday 18 April 2024 at approximately 07:30 CEST. EQT will host a conference call at 08:30 CEST to present the report, followed by a Q&A session.

The presentation and a video link for the webcast will be available here from the time of the publication of the Q1 Announcement.

To participate by phone and ask questions during the Q&A, please register here in advance. Upon registration, you will receive your personal dial-in details.

The webcast can be followed live here and a recording will be available afterwards.

Information on EQT AB’s financial reporting

Advertisement
Stake.com

The EQT AB Group has a long-term business model founded on a promise to its fund investors to invest capital, drive value creation and create consistent attractive returns over a 5 to 10-year horizon. The Group’s financial model is primarily affected by the size of its fee-generating assets under management, the performance of the EQT funds and its ability to recruit and retain top talent.

The Group operates in a market driven by long-term trends and thus believes quarterly financial statements are less relevant for investors. However, in order to provide the market with relevant and suitable information about the Group’s development, EQT publishes quarterly announcements with key operating numbers that are relevant for the business performance (taking Nasdaq’s guidance note for preparing interim management statements into consideration). In addition, a half-year report and a year-end report including financial statements and further information relevant for investors is published. Finally, EQT also publishes an annual report including sustainability reporting.

Contact
Olof Svensson, Head of Shareholder Relations, +46 72 989 09 15
EQT Shareholder Relations, [email protected]

Rickard Buch, Head of Corporate Communications, +46 72 989 09 11
EQT Press Office, [email protected], +46 8 506 55 334

This information was brought to you by Cision http://news.cision.com

Advertisement
Stake.com

https://news.cision.com/eqt/r/invitation-to-presentation-of-eqt-ab-s-q1-announcement-2024,c3956826

The following files are available for download:

https://mb.cision.com/Main/87/3956826/2712771.pdf

Invitation to presentation of EQT AB’s Q1 Announcement 2024

https://news.cision.com/eqt/i/eqt-ab-group,c3285895

Advertisement
Stake.com

EQT AB Group

 

View original content:https://www.prnewswire.co.uk/news-releases/invitation-to-presentation-of-eqt-abs-q1-announcement-2024-302109147.html

Continue Reading

Fintech PR

Kia presents roadmap to lead global electrification era through EVs, HEVs and PBVs

Published

on

kia-presents-roadmap-to-lead-global-electrification-era-through-evs,-hevs-and-pbvs
  • Kia drives forward transformation into ‘Sustainable Mobility Solutions Provider’
  • Roadmap enables Kia to proactively respond to uncertainties in mobility industry landscape, including changes in EV market
  • Company to expand EV line-up with more models; enhance HEV line-up to manage fluctuation in EV demand
    • Goal to sell 1.6 million EVs annually in 2030, introducing 15 models
    • PBV to play a key role in Kia’s growth, targeting 250,000 PBV sales annually by 2030 with PV5 and PV7 models
  • Kia to invest KRW 38 trillion by 2028, including KRW 15 trillion for future business
  • 2024 business guidance : KRW 101 tln in revenue with KRW 12 tln in operating profit; operating profit margin of 11.9% on sales of 3.2 million units globally
  • CEO reaffirms Kia’s commitment to ESG management

SEOUL, South Korea, April 5, 2024 /PRNewswire/ — Kia Corporation (Kia) today shared an update on its future strategies and financial targets at its CEO Investor Day in Seoul, Korea.

Based on its innovative achievements in the years since the announcement of mid-to-long-term business initiatives, Kia is focusing on updating its 2030 strategy announced last year and further strengthening its business strategy in response to uncertainties across the global mobility industry landscape.

During the event, Kia updated its mid-to-long-term business strategy with a focus on electrification, and its PBV business. Kia reiterated its 2030 annual sales target of 4.3 million units, including 1.6 million units of electric vehicles (EVs). The 2030 4.3 million annual sales target is 34.4 percent higher than the brand’s 2024 annual goal of 3.2 million units.

The company also plans to become a leading EV brand by selling a higher percentage of electrified models among its total sales, including hybrid electric vehicles (HEV), plug-in hybrid (PHEV), and battery EVs, projecting electrified model sales of 2.48 million units annually or 58 percent of Kia’s total sales in 2030.

“Following our successful brand relaunch in 2021, Kia is enhancing its global business strategy to further the establishment of an innovative EV line-up and accelerate the company’s transition to a sustainable mobility solutions provider,” said Ho Sung Song, President and CEO of Kia. “By responding effectively to changes in the mobility market and efficiently implementing mid-to-long-term strategies, Kia is strengthening its brand commitment to the wellbeing of customers, communities, the global society, and the environment.”

Advertisement
Stake.com

Photo – https://mma.prnewswire.com/media/2380039/Photo_1__2024_CEO_Investor_Day.jpg
PDF – https://mma.prnewswire.com/media/2380040/Press_Release__2024_Kia_CEO_Investor_Day_240405.pdf

Cision View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/kia-presents-roadmap-to-lead-global-electrification-era-through-evs-hevs-and-pbvs-302109142.html

Continue Reading

Fintech PR

BioVaxys Technology Corp. Provides Bi-Weekly MCTO Status Update

Published

on

biovaxys-technology-corp.-provides-bi-weekly-mcto-status-update

VANCOUVER, BC, April 4, 2024 /PRNewswire/ — BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTCQB: BVAXF) (the “Company“) is providing this bi-weekly update on the status of the management cease trade order granted on February 29, 2024 (the “MCTO“), by its principal regulator, the Ontario Securities Commission (the “OSC“), under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203“), following the Company’s announcement on February 21, 2024 (the “Default Announcement“), that it was unable to file its audited annual financial statements for the year ended October 31, 2023, its management’s discussion and analysis of financial statements for the year ended October 31, 2023, its annual information form for the year ended October 31, 2023, and related filings (collectively, the “Required Annual Filings“). Under National Instrument 51-102, the Required Annual Filings were required to be made no later than February 28, 2024.

As a result of the delay in filing the Required Annual Filings, the Company was unable to file its interim financial statements for the three months ended January 31, 2024, its management’s discussion and analysis of financial statements for the three months ended January 31, 2024, and related filings (collectively, the “Required Interim Filings“). Under National Instrument 51-102, the Required Interim Filings were required to be made no later than April 1, 2024.

The Company anticipates filing the Required Annual Filings by April 30, 2024. The auditor of the Company requires additional time to complete its audit of the Company, including the Company’s recent acquisition of all intellectual property, immunotherapeutics platform technologies, and clinical stage assets of the former IMV Inc. that closed on February 16, 2024. In addition, the Company anticipates filing the Required Interim Filings immediately after the filing of the Required Annual Filings.

Except as herein disclosed, there are no material changes to the information contained in the Default Announcement. In addition, (i) the Company is satisfying and confirms that it intends to continue to satisfy the provisions of the alternative information guidelines under NP 12-203 and issue bi-weekly default status reports for so long as the delay in filing the Required Annual Filings and/or Required Interim Filings is continuing, each of which will be issued in the form of a press release; (ii) the Company does not have any information at this time regarding any anticipated specified default subsequent to the default in filing the Required Annual Filings and Required Interim Filings; (iii) the Company is not subject to any insolvency proceedings; and (iv) there is no material information concerning the affairs of the Company that has not been generally disclosed.

About BioVaxys Technology Corp.

Advertisement
Stake.com

BioVaxys Technology Corp. (www.biovaxys.com), a biopharmaceuticals company registered in British Columbia, Canada, is a clinical-stage biopharmaceutical company dedicated to improving patient lives with novel immunotherapies based on the DPX™ immune-educating technology platform and it’s HapTenix© ‘neoantigen’ tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization, and other immunological fields. The Company’s clinical stage pipeline includes maveropepimut-S which is in Phase II clinical development for advanced Relapsed-Refractory Diffuse Large B Cell Lymphoma (DLBCL) and platinum resistant ovarian cancer, and BVX-0918, a personalized immunotherapeutic vaccine using it proprietary HapTenix© ‘neoantigen’ tumor cell construct platform which is soon to enter Phase I in Spain for treating refractive late-stage ovarian cancer. The Company is also capitalizing on its tumor immunology know-how and creation of a unique library of T-lymphocytes & other datasets post-vaccination with its personalized immunotherapeutic vaccines to utilize predictive algorithms and other technologies to identify new targetable tumor antigens. BioVaxys common shares are listed on the CSE under the stock symbol “BIOV” and trade on the Frankfurt Bourse (FRA: 5LB) and in the US (OTCQB: BVAXF). For more information, visit www.biovaxys.com and connect with us on X and LinkedIn.

ON BEHALF OF THE BOARD

Signed “James Passin
James Passin, Chief Executive Officer
Phone: +1 646 452 7054

Logo – https://mma.prnewswire.com/media/1430981/BIOVAXYS_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/biovaxys-technology-corp-provides-bi-weekly-mcto-status-update-302108920.html

Advertisement
Stake.com
Continue Reading

Trending